Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
We are advancing novel antigen modulation technology that controls T cells to guide the immune system.
Oxford Endovascular are developing a novel treatment for treating brain aneurysms.
Genomics plc aiming to lead the genomic transformation of healthcare.
A med-tech startup that has developed a passive and contactless device for monitoring nocturnal symptoms and environmental metrics at home.
Proxisense has developed extreme environment proximity sensors and fluid contamination systems.
Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.
Navenio is a software company that provides location positioning services for indoor environments through its mobile app.
Oxford Ionics is a quantum computing startup that provides innovations for the development of accurate and dependable quantum computers.
Building the most advanced global infrastructure for People Science.
SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.
Mind Foundry is an Oxford University company that has developed an AI platform to solve the world's most important problems.
Oxford VR is an evidence-based immersive treatment for serious mental illness and behavioral health.
Kesmalea Therapeutics is a biotech startup focusing on the discovery of novel protein degraders.
BehaVR develops evidence-based, immersive, digital therapeutics for behavioral health using Virtual Reality.
Lab-quality diagnostics for anyone, anywhere, at any time.
Analytics to maximise environmental and social investment returns
Xerion Healthcare is the technology commercialization company of University of Oxford.
Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases
Living Optics is an imaging technology company.
Opsydia is set to disrupt a number of industries by its ability to create practically invisible structures inside transparent materials.
Brill Power is a Battery Intelligence Platform that develops pioneering battery management technology.
MiroBio is Harnessing the natural control mechanisms of the immune system.
ORCA Computing is building the first scalable and flexible quantum computer powered by photonics.
Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors.
Oxford Science Enterprises has invested in 138 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Oxford Science Enterprises's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Therapeutics. The firm invests across 51 different industry categories.
Among tracked funding rounds, MiroBio received $97.0M in a Series B round. Oxford Science Enterprises's total known invested capital is $3.3B.
Oxford Science Enterprises's average investment size is $23.9M across its portfolio of 138 companies.
Recent Oxford Science Enterprises portfolio additions include Greywolf Therapeutics, Oxford Endovascular, Genomics, Albus Health, Proxisense. These companies were founded in 2020 or later.